VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects. - Test2 - elhamkhani - TriplyDB

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

http://www.wikidata.org/entity/Q35287391

about

VS-501: A NOVEL, NON-ABSORBED, CALCIUM- AND ALUMINUM-FREE, HIGHLY EFFECTIVE PHOSPHATE BINDER DERIVED FROM NATURAL PLANT POLYMER Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder.CCSVI is associated with multiple sclerosis.Therapeutic application of vitamin D receptor ligands: an updated patent review.Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.Indoxyl sulfate potentiates endothelial dysfunction via reciprocal role for reactive oxygen species and RhoA/ROCK signaling in 5/6 nephrectomized rats.

P2860

Q34120727-7E0767AD-CC45-49C5-A9B0-5C7711AE69A0 Q35086461-2BCD657F-CAB2-4769-A9CA-03F4A0B0DEF9 Q37034750-ACF4755F-E9D6-479B-8977-40EDCDFF4FA5 Q38042767-3C3794E6-F7F0-4AF5-B760-5CC4A32AD097 Q38592175-CCDCB1D5-6B70-414B-9426-3DDFB017FF85 Q43658115-9C647783-555E-47BB-AE16-60D365FDB5B8 Q46406577-24C36850-DD95-4152-9B19-FB81580B1E99

P2860

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

http://www.wikidata.org/entity/Q35287391

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@ast

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@en

type

label

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@ast

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@en

prefLabel

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@ast

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@en

P1433

Q35287391-1CEE56D6-D89E-4653-9A42-86836F24C9C3

P1476

Q35287391-95E1AD65-9661-4F3C-964F-8959EB3A02CA

P2093

Q35287391-A833EABC-8FD2-43AC-8130-A39F0CFE09E8

Q35287391-BDA94FE1-3BB3-40B2-A910-98ABA37F92E4

Q35287391-C79090C7-02DA-4DAF-96E5-7052869BE8F3

Q35287391-CE22D50B-2F47-4BAE-9431-ECF57723A467

P2860

Q35287391-03449172-98C8-4947-A7C3-A1769AF997BC

Q35287391-0B6B9194-962C-4609-B2F9-679C7ED5FD5F

Q35287391-0B88BEFD-8ECC-4FAB-998E-B29AB2337CEB

Q35287391-1D931248-FE9F-4500-96B3-FDD169D45FA1

Q35287391-20038F25-7096-4DEC-8FD3-85737416C22A

Q35287391-22BD7DA1-E0CD-4298-8DBF-CDC9D7CD7C13

Q35287391-2AE93DE4-85FC-4AED-ADE0-C8AA86137C2D

Q35287391-398F8860-967D-436F-811E-09CD60233CFA

Q35287391-4044B003-13B5-4337-96D5-711ED293B79E

Q35287391-458C9F85-D18B-4651-971C-19E1DB143812

P304

Q35287391-F5DB9A87-3474-47C0-9FCF-49FAA44DD601

P31

Q35287391-4A8F6889-1812-49DF-9531-E24CF7E397D2

P356

Q35287391-B4FBC5AB-53B0-4342-B0A4-F7B52267437E

P407

Q35287391-8C97FA8E-79DE-4FCA-84F0-7913199F412E

P433

Q35287391-7568B0F0-8C99-4B38-ACCD-C073F35AF95F

P478

Q35287391-46A97D0D-5990-4C1A-9F37-ECFDE87A15B7

P577

Q35287391-C97374E3-4B40-4796-B15C-AD58698C6F07

P5875

Q35287391-ECA27575-42D9-4724-837C-09ADF2ABC6BE

P698

Q35287391-2FA6F31B-B237-4F51-AB9B-90D7CFAA7B48

P921

Q35287391-D4521773-C176-439E-A274-25FB65830A5F

P932

Q35287391-23E7EB12-6642-497E-8E8B-5D4FA02C12AA

P356

J.1476-5381.2011.01473.X

P1433

British Journal of Pharmacology

P1476

VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

@en

P2093

J Ruth Wu-Wong

http://www.w3.org/2001/XMLSchema#string

Masaki Nakane

http://www.w3.org/2001/XMLSchema#string

Megumi Kawai

http://www.w3.org/2001/XMLSchema#string

Yung-Wu Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells

Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA).

Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats.

Myocardial effects of VDR activators in renal failure

Premature cardiovascular disease in chronic renal failure.

Vitamin D analogues for the management of secondary hyperparathyroidism.

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

P304

551-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01473.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2b

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51112843

http://www.w3.org/2001/XMLSchema#string

P698

21557735

http://www.w3.org/2001/XMLSchema#string

P921

P932

3188908

http://www.w3.org/2001/XMLSchema#string